peramivir in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
peramivir is authorized only for hospitalized adult and pediatric patients for whom therapy with an i.v.
"BioCryst has worked with HHS to enable the Government to rapidly deploy an initial supply of peramivir, and we are prepared to deliver more."
To prepare for peramivir orders that BioCryst may receive from the U.S. or other governments during this pandemic emergency, BioCryst is completing production of approximately 130,000 courses of i.v.
Forward-Looking StatementsThis press release contains forward-looking statements, including statements regarding future results, performance or achievements.